Table 2.
The microbial diversity of MAM and LM in all the subjects.
| OTU | Chao | Ace | Shannon | |||
|---|---|---|---|---|---|---|
| Mean ± SE | C-LM | 666.44 ± 51.90 | 75.11 ± 11.15 | 76.92 ± 10.67 | 2.28 ± 0.10 | |
| D-LM | 715.16 ± 24.83 | 55.84 ± 1.72 | 59.27 ± 2.14 | 1.92 ± 0.06 | ||
| C-MAM | 660.07 ± 39.3 | 154.81 ± 8.44 | 160.57 ± 8.57 | 2.74 ± 0.09 | ||
| D-MAM | 762.5 ± 38 | 170.74 ± 8.7 | 174.19 ± 8.85 | 2.72 ± 0.1 | ||
| p-value | HCs vs. IBS-D | LM | 0.12 | 0.71 | 0.52 | 0.03 |
| MAM | 0.07 | 0.3 | 0.35 | 0.7 | ||
| LM vs. MAM | Control | 0.66 | 0 | 0 | 0.001 | |
| IBS-D | 0.4 | 0 | 0 | 0 | ||
C-LM, luminal microbiota in healthy controls; D-LM, luminal microbiota in IBS-D; C-MAM, mucosa-associated microbiota in healthy controls; D-MAM, mucosa-associated microbiota in IBS-D.